Pancreatic cancer has long been a death sentence, and a rapid one at that, but a new two-a-day pill has seen patients live twice as long even after chemotherapy fails. “Surviving” cancer refers to living more than 5 years post-diagnosis. Under that criteria, just 3% of patients survive pancreatic cancer, which usually requires particularly grueling […] The post FDA Immediately Approves Drug That’s Doubling Lifespan for Late Pancreatic Cancer Patients appeared first on Good News Network.
Read the full story at Good News Network.